Skip to main content
Abpro Bio Co., Ltd. logo

Abpro Bio Co., Ltd. — Investor Relations & Filings

Ticker · 195990 ISIN · KR7195990007 KO Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2025-08-26 Major Shareholding Noti…
Country KR South Korea
Listing KO 195990

About Abpro Bio Co., Ltd.

https://abpro.co/

Abpro Bio Co., Ltd. is a company engaged in the manufacture and sale of precision machine tools. Its primary products include tapping centers, 2-spindle machining centers, and other specialized industrial machinery. In addition to its core manufacturing operations, the company has diversified its business to include a biotechnology division. This division is involved in the development of next-generation antibody therapeutics, often through exclusive development agreements and collaborations with strategic partners.

Recent filings

Filing Released Lang Actions
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding the cancellation of a stock collateral agreement involving the company's largest shareholder. It details the specific transaction, the parties involved, and the impact on the shareholding structure. Since this is a specific regulatory disclosure regarding capital structure and share collateralization that does not fit into the other specialized categories like 'Director's Dealing' or 'Share Issue', it is classified as a general Regulatory Filing (RNS).
2025-08-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. This type of filing is required when an entity or individual acquires a significant stake (typically 5% or more, or changes in control) in a publicly traded company. It details the reporting entity (Polymath Investment Association), the target company (ABProBio), the purpose of holding (influence on management), and changes in shareholding or collateral status. This falls under the 'Major Shareholding Notification' category.
2025-08-26 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (에이비프로바이오) regarding a 'Correction Report' (정정신고) for a 'Stock Collateral Agreement' (주식 담보제공 계약). This type of disclosure, which details changes in collateralized shares by a major shareholder, falls under general regulatory announcements for corporate events that do not fit into specific categories like earnings or dividends. As it is a formal regulatory filing required by the exchange, it is classified as RNS.
2025-08-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. This document details the shareholding status, changes in ownership, and purpose of holding (influencing management) by a specific entity (Polymath Investment Association) in a listed company (ABProBio). This falls under the category of Major Shareholding Notification.
2025-08-19 Korean
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from a Korean company (ABPROBIO) regarding the confirmation of audit results and financial status (specifically mentioning capital impairment). It is a standard regulatory disclosure form used in the Korean market to report audit opinions and key financial metrics, which falls under the 'Regulatory Filings' category as it does not fit into the specific categories of a full annual report or a simple announcement of a report. H1 2025
2025-08-14 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '에이비프로바이오' (Abpro Bio Co., Ltd.) covering the period from January 1, 2025, to June 30, 2025. It contains detailed corporate information, financial data, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.